Sprout Pharmaceuticals (United States) has no DMF, CEP or site registration linked in our records. 2 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Sprout Pharmaceuticals: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sprout-pharmaceuticals

Overview

Sprout Pharmaceuticals is a private pharmaceutical company that focuses on developing medications for women’s health. It gained prominence with the approval of its flagship product, Addyi, designed for the treatment of hypoactive sexual desire disorder (HSDD) in women.

Therapeutic areas

FDA compliance signals

2 FDA enforcement records linked to this company.

  • warning_letter2025-05-29

    FDA Warning Letter (drug product)

  • warning_letter2020-08-31

    FDA Warning Letter (drug product)

For suppliers

Is this Sprout Pharmaceuticals?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.